James Ladesich MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 2800 Clay Edwards Dr in North Kansas City, Missouri.
There is an additional office location, for a total of two, for James Ladesich MD that can be viewed further down.
They're a part of the: Meritas Health Corporation medical group which has around 349 members. You can call their office at 816-691-2021 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Kansas School Of Med (kc/wich/sal) and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
James Ladesich MD
Meritas Health Corporation
2800 Clay Edwards Dr
North Kansas City, Missouri 64116
816-691-2021
Phone: 816-691-2021
Enter a starting address:
Medical School: University Of Kansas School Of Med (kc/wich/sal)
Graduation Year: 2003
The Primary Medical Specialty for James Ladesich MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 21
PAC (PECOS ID)#: 7911909452
NPI #: 1962439539
NPI Created On: 06/27/2006
NPI Last Updated Listed as: 06/25/2010
Primary Taxonomy Code: 207RP1001X
License Number:
2006006312
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English, Spanish.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $21
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 788864541
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Cardiology
Name of Drug #1: OPSUMIT
Open Associated Drug #1: 66215-501-30
Drug or Biological: Drug
Product Category #2: Cardiology
Name Of Drug #2:: UPTRAVI
Associated Drug #2: 66215-602-14
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795196251
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ANTI-INFECTIVE
Name of Drug #1: AVYCAZ
Open Associated Drug #1: 0456-2700-10
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795196233
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ANTI-INFECTIVE
Name of Drug #1: AVYCAZ
Open Associated Drug #1: 0456-2700-10
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795196239
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ANTI-INFECTIVE
Name of Drug #1: AVYCAZ
Open Associated Drug #1: 0456-2700-10
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 795196245
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ANTI-INFECTIVE
Name of Drug #1: TEFLARO
Open Associated Drug #1: 0456-0600-10
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 802490493
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: IMMUNOLOGY
Name of Drug #1: NUCALA
Open Associated Drug #1: 0173-0881-01
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 802643493
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: RESPIRATORY
Name of Drug #1: TRELEGY ELLIPTA
Open Associated Drug #1: 0173-0887-14
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 802883073
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: RESPIRATORY
Name of Drug #1: ANORO ELLIPTA
Open Associated Drug #1: 0173-0869-06
Drug or Biological: Drug
Product Category #2: RESPIRATORY
Name Of Drug #2:: TRELEGY ELLIPTA
Associated Drug #2: 0173-0887-14
Payments Total: $15
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Record ID:: 783421217
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Cardiovascular
Name of Drug #1: ELIQUIS
Open Associated Drug #1: 0003-0894-31
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835920867
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Immunology
Name of Drug #1: Xolair
Open Associated Drug #1: 50242-040-62
Drug or Biological: Biological
Product Category #2: Immunology
Name Of Drug #2:: Esbriet
Associated Drug #2: 50242-121-01
1. Meritas Health Corporation
2790 Clay Edwards Dr
North Kansas City, MO 64116
Group Members: 349
Enter a starting address:
2790 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
2800 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
2790 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
2800 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
2790 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
2800 Clay Edwards Dr
North-kansas-city, MO
Meritas Health Corporation
6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice
2800 Clay Edwards Dr
North Kansas City Mo 64116-3220
Meritas Health Corporation
Family Practice
6450 N Chatham Ave
Kansas City Mo 64151-2403
Meritas Health Corporation
Family Practice
2700 Clay Edwards Dr
N Kansas City Mo 64116-3270
Meritas Health Corporation
Internal Medicine
2790 Clay Edwards Dr
North Kansas City Mo 64116-3274
Meritas Health Corporation
Cardiovascular Disease (cardiology)
9411 N Oak Trafficway
Kansas City Mo 64155-2281
Meritas Health Corporation
Cardiovascular Disease (cardiology)
View all 349 members of Meritas Health Corporation medical group